Based in Rochester, Michigan, OptimizeRx Corporation OTCQB:OPRX is a health technology software company that is revolutionizing the point of care experience through technology to improve clinical decisions and outcomes. OptimizeRx s unique consumer and physician platforms help patients better afford and comply with their medicines and healthcare products, while offering pharmaceutical and healthcare companies effective ways to expand awareness, access and adherence to their medications. OptimizeRx core product replaces drug samples with electronic trial vouchers and copay coupon savings that are electronically added to an e Prescription and sent electronically to the pharmacy and is integrated within leading electronic health record EHR platforms in the country, including Allscripts, DrFirst, NewCrop, Quest Diagnostics, Practice Fusion and other EHRs to reach over , healthcare providers. In turn, OptimizeRx promotes patient savings and support from the world s largest pharmaceutical companies, including Pfizer, Merck, Lilly, Novartis, AstraZeneca and many others. For more information, visit www.optimizerx.com.
Quote | OptimizeRx Corporation (NASDAQ:OPRX)
Last: | $10.12 |
---|---|
Change Percent: | -8.18% |
Open: | $9.52 |
Close: | $10.12 |
High: | $10.2 |
Low: | $9.41 |
Volume: | 489,023 |
Last Trade Date Time: | 04/26/2024 03:00:00 am |
News | OptimizeRx Corporation (NASDAQ:OPRX)
2024-04-26 10:00:34 ET More on Health Care Select Sector SPDR XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance BofA watched clients retract $2B last week as the S&P dropped ...
1Q24 revenue expected to grow over 40% year-over-year and come in between $18.5 - $19.2 million First quarter revenue and adjusted EBITDA to come in ahead of consensus DAAP adoption and cross selling activities are tracking ahead of internal expectations WALTHAM, Mass...
Message Board Posts | OptimizeRx Corporation (NASDAQ:OPRX)
Subject | By | Source | When |
---|---|---|---|
Just read where $OPRXs board unanimously approved a | 4retire | investorshub | 03/16/2023 3:48:56 AM |
glucoberry: Gluco Berry Reviews - On the off chance that we consider clinical terms, sugar is the le | glucoberry | investorshangout | 03/14/2023 2:27:06 PM |
whytestocks: $OPRX News Article - OptimizeRx Authorizes $15 Million Share Repurchase Program | whytestocks | investorshangout | 03/14/2023 2:15:55 PM |
Just a few days past the 10K and | 4retire | investorshub | 03/14/2023 4:37:28 AM |
On another note, $OPRX was recently removed from | 4retire | investorshub | 03/08/2023 11:03:21 PM |
News, Short Squeeze, Breakout and More Instantly...
OptimizeRx Corporation Company Name:
OPRX Stock Symbol:
NASDAQ Market:
OptimizeRx Corporation Website:
1Q24 revenue expected to grow over 40% year-over-year and come in between $18.5 - $19.2 million First quarter revenue and adjusted EBITDA to come...
1Q24 revenue expected to grow over 40% year-over-year and come in between $18.5 - $19.2 million First quarter revenue and adjusted EBITDA to come in ahead of consensus DAAP adoption and cross selling activities are tracking ahead of internal expectations WALTHAM, Mass...
WALTHAM, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, has published its Environment...